Repurposed medicines: a scan of the non-commercial clinical research landscape.

The article examines the landscape of repurposed medicines evaluated by non-commercial entities, focusing on identifying new uses for existing drugs to address unmet medical needs. Topics include the role of the NIHR Innovation Observatory in scanning clinical trial registries, the classification of 528 technologies for new indications, and the support for the NHS England Medicines Repurposing Programme.